IDEXX LABORATORIES INC /DE Quarterly Other Liabilities, Noncurrent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Idexx Laboratories Inc /De quarterly Other Liabilities, Noncurrent history and growth rate from Q2 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Other Liabilities, Noncurrent for the quarter ending September 30, 2024 was $62.9M, a 4.43% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $62.9M +$2.67M +4.43% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $53.4M -$10.9M -16.9% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $66.3M -$4.6M -6.5% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $65.5M -$2.06M -3.05% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $60.2M -$10.7M -15.1% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $64.3M -$5.49M -7.87% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $70.9M -$984K -1.37% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $67.6M -$3.35M -4.73% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $71M -$2.04M -2.8% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $69.8M -$15.3M -18% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $71.8M -$11.7M -14% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $70.9M -$14.7M -17.1% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $73M -$6.67M -8.37% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $85M +$836K +0.99% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $83.5M +$2.26M +2.78% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $85.6M +$4.44M +5.47% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $79.7M +$2.59M +3.36% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $84.2M +$4.86M +6.12% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $81.3M -$1.27M -1.54% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $81.2M -$3.66M -4.32% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $77.1M -$4.42M -5.42% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $79.4M -$3.92M -4.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $82.6M -$2.01M -2.38% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $84.8M -$10.9M -11.4% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $81.5M +$31.9M +64.4% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $83.3M +$34M +69.1% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $84.6M +$42.6M +101% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $95.7M +$56.8M +146% Dec 31, 2017 10-K 2019-02-15
Q3 2017 $49.6M +$15M +43.3% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $49.2M +$18.9M +62.3% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $42M +$11.7M +38.4% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $38.9M +$10.2M +35.7% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $34.6M +$4.93M +16.6% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $30.3M -$1.01M -3.21% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 $30.4M -$666K -2.15% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $28.7M -$3.67M -11.3% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $29.7M -$1.93M -6.1% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $31.3M +$670K +2.19% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $31M -$733K -2.31% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $32.4M +$1.15M +3.68% Dec 31, 2014 10-K 2016-02-17
Q3 2014 $31.6M +$2.81M +9.78% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $30.7M +$4.9M +19% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $31.8M +$6.94M +28% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $31.2M +$7.32M +30.6% Dec 31, 2013 10-K 2015-02-17
Q3 2013 $28.8M +$5.89M +25.7% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $25.8M +$4.5M +21.2% Jun 30, 2013 10-Q 2013-07-23
Q1 2013 $24.8M +$4.8M +24% Mar 31, 2013 10-Q 2013-04-23
Q4 2012 $23.9M +$6.17M +34.8% Dec 31, 2012 10-K 2014-02-18
Q3 2012 $22.9M +$7.61M +49.8% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $21.3M +$8.31M +64.1% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $20M +$7.74M +63% Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $17.7M +$6.69M +60.5% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $15.3M +$2.85M +23% Sep 30, 2011 10-Q 2011-10-21
Q2 2011 $13M +$1.23M +10.5% Jun 30, 2011 10-Q 2011-07-22
Q1 2011 $12.3M Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $11M Dec 31, 2010 10-K 2012-02-17
Q3 2010 $12.4M Sep 30, 2010 10-Q 2010-10-22
Q2 2010 $11.7M Jun 30, 2010 10-Q 2010-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.